Published by Align Wellness
Jess reports on testosterone, menopause and the hormonal shifts of midlife, with close attention to how regulatory changes reach patients.
AnalysisLabel Change
In November 2025, regulators removed most of the boxed warning that had defined hormone therapy since 2002. The science behind the shift is about timing, and the remaining risks are still worth a real conversation.
AnalysisMen's Health
For a decade, the heart-risk question hung over testosterone therapy. A 5,246-man randomized trial answered a lot of it. It also raised new questions about who should be treated and how.
ExplainerThyroid
Mildly elevated TSH with normal thyroid hormone is common after 60. A large European trial found that treating it in older adults did not improve how people felt.
